Results 201 to 210 of about 164,783 (254)
Some of the next articles are maybe not open access.
Interferon beta in multiple sclerosis
Neurology, 1993Interferon beta 1B (IFNbeta1b) lessens multiple sclerosis (MS) attack frequency and accumulating disease burden as assessed by MRI. The agent is an immune system modulator. The immune response in MS is thought to involve a delayed-type hypersensitivity (DTH) response mediated by Th1 type T cells. IFNbeta1b lessens expression of MHC-class II proteins on
openaire +2 more sources
Neurology, 2005
Many women with multiple sclerosis (MS) ask about the risks of pregnancy before starting (or while on) disease-modifying therapies (DMTs). At least two-thirds of patients with MS are women, and the majority are in their childbearing years at the time of clinical onset and diagnosis.
Emmanuelle Waubant, A. Dessa Sadovnick
openaire +1 more source
Many women with multiple sclerosis (MS) ask about the risks of pregnancy before starting (or while on) disease-modifying therapies (DMTs). At least two-thirds of patients with MS are women, and the majority are in their childbearing years at the time of clinical onset and diagnosis.
Emmanuelle Waubant, A. Dessa Sadovnick
openaire +1 more source
[Interferon-beta retinopathy].
Revue neurologique, 2010Interferon-alpha associated retinopathy is an ocular complication of hepatitis C treatment well established in the literature. But, there are far fewer reports on multiple sclerosis related interferon-beta retinopathy.A 58-year-old male while receiving subcutaneous interferon-beta 1a 44microg thrice a week since 2001 for multiple sclerosis developed ...
M, Sallansonnet-Froment +7 more
openaire +1 more source
SARS-CoV-2 variant biology: immune escape, transmission and fitness
Nature Reviews Microbiology, 2023Alessandro Maria Carabelli +2 more
exaly